Rare diseases
Investigational molecules
Locations
500 Unicorn Park Drive Floor Third, 01801-3377, United States
Clinical research is centred on melanoma, including metastatic melanoma and advanced melanoma, with a strong focus on immune-based treatment approaches and disease control in patients with limited options.
Interest extends to patients whose disease has progressed after prior immunotherapy, reflecting a therapeutic emphasis on checkpoint blockade combinations in difficult-to-treat cutaneous malignancies.
Replimune Group Inc. runs clinical trials in conditions such as Malignant melanoma, Hepatocellular carcinoma, Metastatic malignant melanoma, Uveal melanoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceFranceFrance
BulgariaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
